Surgery Partners, Inc.

NasdaqGS:SGRY Stok Raporu

Piyasa değeri: US$3.8b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Surgery Partners Yönetim

Yönetim kriter kontrolleri 3/4

Surgery Partners' CEO'su J. Evans, Jan2020 tarihinde atandı, in görev süresi 4.75 yıldır. in toplam yıllık tazminatı $ 6.46M olup, şirket hissesi ve opsiyonları dahil olmak üzere 16.3% maaş ve 83.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.36% ine doğrudan sahiptir ve bu hisseler $ 14.82M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.3 yıl ve 6.5 yıldır.

Anahtar bilgiler

J. Evans

İcra Kurulu Başkanı

US$6.5m

Toplam tazminat

CEO maaş yüzdesi16.3%
CEO görev süresi4.8yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi3.3yrs
Yönetim Kurulu ortalama görev süresi6.5yrs

Son yönetim güncellemeleri

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Recent updates

Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger

Oct 05
Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger

Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Jul 25
Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Jul 13
Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Jun 21
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Mar 27
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

CEO Tazminat Analizi

J. Evans'un ücretlendirmesi Surgery Partners'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$34m

Mar 31 2024n/an/a

US$600k

Dec 31 2023US$6mUS$1m

-US$12m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$92m

Dec 31 2022US$6mUS$1m

-US$55m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$38m

Dec 31 2021US$4mUS$1m

-US$81m

Sep 30 2021n/an/a

-US$86m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$150m

Dec 31 2020US$4mUS$916k

-US$156m

Sep 30 2020n/an/a

-US$179m

Jun 30 2020n/an/a

-US$132m

Mar 31 2020n/an/a

-US$119m

Dec 31 2019US$5mUS$435k

-US$110m

Tazminat ve Piyasa: J. 'ın toplam tazminatı ($USD 6.46M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 6.79M ).

Tazminat ve Kazançlar: J. şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

J. Evans (47 yo)

4.8yrs

Görev süresi

US$6,457,600

Tazminat

Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Wayne DeVeydt
Executive Chairman6.8yrsUS$250.00k0.080%
$ 3.0m
J. Evans
CEO & Director4.8yrsUS$6.46m0.36%
$ 13.8m
David Doherty
Executive VP & CFO2.7yrsUS$3.52m0.076%
$ 2.9m
Jennifer Baldock
Executive VP and Chief Administrative & Development Officer4.7yrsUS$3.09m0.15%
$ 5.5m
Bradley Owens
President of National Group4.8yrsUS$1.61m0.057%
$ 2.2m
Marissa Brittenham
Executive VP & Chief Strategy Officer2.8yrsUS$1.68m0.031%
$ 1.2m
Neil Zieselman
Senior Vice President of Corporate Finance & Controller2.4yrsVeri yokVeri yok
Varun Gadhok
Senior VP & Chief Information Officer3.3yrsVeri yokVeri yok
Roxanne Womack
Senior VP & Chief Compliance Officer5.9yrsVeri yokVeri yok
Spencer Clark
General Counsel & Senior VPless than a yearVeri yokVeri yok
Danielle Burkhalter
Executive VP & Chief Human Resources Officer1.7yrsVeri yok0.024%
$ 914.1k
Anthony Taparo
Chief Growth Officer5.2yrsUS$1.30m0.081%
$ 3.1m

3.3yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: SGRY 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Wayne DeVeydt
Executive Chairman6.8yrsUS$250.00k0.080%
$ 3.0m
J. Evans
CEO & Director4.8yrsUS$6.46m0.36%
$ 13.8m
Clifford Adlerz
Director7yrsUS$260.00k0.040%
$ 1.5m
Blair Hendrix
Director3.4yrsVeri yokVeri yok
William Turner
Independent Director8.8yrsUS$285.00k0.054%
$ 2.0m
Patricia Maryland
Independent Director3.7yrsUS$260.00k0.014%
$ 533.6k
Teresa DeLuca
Independent Director8.1yrsUS$280.00k0.046%
$ 1.8m
John Deane
Independent Director5.4yrsUS$260.00k0.022%
$ 824.7k
T. O'Reilly
Director7.2yrsVeri yokVeri yok
Andrew Kaplan
Director6.2yrsVeri yokVeri yok

6.5yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SGRY 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).